Cardiac function and lipid distribution in rats fed a high-fat diet: In vivo magnetic resonance imaging and spectroscopy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 11, 2013, Pages

  Nagarajan, Vijayasarathi ^a,b   Gopalan, Venkatesh ^a   Kaneko, Manami ^a   Angeli, Veronique ^c   Gluckman, Peter ^b   Richards, Arthur Mark ^d   Kuchel, Philip W ^a   Sendhil Velan, S ^a,b,e  

^a AGENCY FOR SCIENCE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

Cardiac function; Cardiac metabolism; EMCL; IMCL

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART WEIGHT; HISTOLOGY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCANNING ELECTRON MICROSCOPY;

CARDIAC FUNCTION; CARDIAC METABOLISM; EMCL; IMCL;

ANIMALS; AZO COMPOUNDS; BLOOD GLUCOSE; BODY WEIGHT; CARDIOMEGALY; COLORING AGENTS; DIET, HIGH-FAT; EATING; HEART; INSULIN RESISTANCE; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIUM; OBESITY; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

EID: 84878750399     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00478.2012     Document Type: Article

References (49)

1. Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition. J Physiol 538: 555-572, 2002.
2. Al-Shafei AIM, Wise RG, Gresham GA, Bronns G, Carpenter TA, Hall LD, Huang CL. Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats. J Physiol 538: 541-553, 2002.
3. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291: H1489-H1506, 2006.
4. Boesch C, Decombaz J, Slotboom J, Kreis R. Observation of intramyocellular lipids by means of 1H magnetic resonance spectroscopy. Proc Nutr Soc 58: 841-850, 1999.
5. Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MRspectroscopy. Magn Reson Med 37: 484-493, 1997.
6. Chu SC, Xu Y, Balschi JA, Springer CS Jr. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn Reson Med 13: 239-262, 1990.
7. Cole M, Murray A, Cochlin L, Heather L, McAleese S, Knight N, Sutton E, Jamil A, Parassol N, Clarke K. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res Cardiol 106: 447-457, 2011.
8. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM, Kirk ML, Potts JL, Hockaday TD. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264-272, 1992.
9. De Feyter HM, Lenaers E, Houten SM, Schrauwen P, Hesselink MK, Wanders RJA, Nicolay K, Prompers JJ. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J 22: 3947-3955, 2008.
10. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32: S157-S163, 2009.
11. Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids 85: 219-225, 2011.
12. Durrant CJ, Hertzberg MP, Kuchel PW. Magnetic susceptibility: further insights into macroscopic and microscopic fields and the sphere of Lorentz. Concepts Magn Reson Part A 18A: 72-95, 2003.
13. Fang CX, Dong F, Thomas DP, Ma H, He L, Ren J. Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol 295: H1206-H1215, 2008.
14. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP. A critical role for PPAR-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
15. Fissoune R, Janier M, Briguet A, Hiba B. In vivo assessment of mouse hindleg intramyocellular lipids by 1H-MR spectroscopy. Acad Radiol 16: 890-896, 2009.
16. Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab 15: 805-812, 2012.
17. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49: 467-472, 2000.
18. Guillerm-Regost C, Louveau I, Sebert SP, Damon M, Champ MM, Gondret F. Cellular and biochemical features of skeletal muscle in obese Yucatan minipigs. Obesity (Silver Spring) 14: 1700-1707, 2006.
19. Hansen PA, Han DH, Marshall BA, Nolte LA, Chen MM, Mueckler M, Holloszy JO. A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms. J Biol Chem 273: 26157-26163, 1998.
20. Howald H, Boesch C, Kreis R, Matter S, Billeter R, Essen-Gustavsson B, Hoppeler H. Content of intramyocellular lipids derived by electron microscopy, biochemical assays, and 1H-MR spectroscopy. J Appl Physiol 92: 2264-2272, 2002.
21. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 347: 305-313, 2002.
22. Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JR. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 55: 101-110, 2013.
23. Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116: 63-68, 2001.
24. Loganathan R, Bilgen M, Al-Hafez B, Alenezy MD, Smirnova IV. Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging. Cardiovasc Diabetol 5: 7, 2006.
25. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
26. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116: 1170-1175, 2007.
27. O'Connor RD, Xu J, Ewald GA, Ackerman JJH, Peterson LR, Gropler RJ, Bashir A. Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: in vivo and ex vivo correlation in human subjects. Magn Reson Med 65: 1234-1238, 2011.
28. Ouwens D, Boer C, Fodor M, de Galan P, Heine R, Maassen J, Diamant M. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia 48: 1229-1237, 2005.
29. Ouwens DM, Diamant M, Fodor M, Habets DD, Pelsers MM, El Hasnaoui M, Dang ZC, van den Brom CE, Vlasblom R, Rietdijk A, Boer C, Coort SL, Glatz JF, Luiken JJ. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 50: 1938-1948, 2007.
30. Park SY, Cho YR, Kim HJ, Higashimori T, Danton C, Lee MK, Dey A, Rothermel B, Kim YB, Kalinowski A, Russell KS, Kim JK. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 Mice. Diabetes 54: 3530-3540, 2005.
31. Pola A, Sadananthan SA, Yaligar J, Nagarajan V, Han W, Kuchel PW, Velan SS. Skeletal muscle lipid metabolism studied by advanced magnetic resonance spectroscopy. Prog Nucl Magn Reson Spectrosc 65: 66-76, 2012.
32. Quarta G, Sado DM, Moon JC. Cardiomyopathies: focus on cardiovascular magnetic resonance. Br J Radiol 84: S296-S305, 2011.
33. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease. Curr Opin Cardiol 11: 490-495, 1996.
34. Rial B, Suttie JJ, Neubauer S, Robson MD, Schneider JE. Identification of two myocardial lipid pools in muscular dystrophy patients by 1H MRS at 3 T (Abstract). Proc Intl Soc Mag Reson Med 19: 1360, 2011.
35. Ruberg FL. Myocardial lipid accumulation in the diabetic heart. Circulation 116: 1110-1112, 2007.
36. Stefan D, Cesare FD, Andrasescu A, Popa E, Lazariev A, Vescovo E, Strbak O, Williams S, Starcuk Z, Cabanas M, Ormondt Dv, and Graveron-Demilly D. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas Sci Technol 20: 104035, 2009.
37. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 107: 1448-1453, 2003.
38. Szczepaniak LS, Dobbins RL, Stein DT, McGarry JD. Bulk magnetic susceptibility effects on the assessment of intra-and extramyocellular lipids in vivo. Magn Reson Med 47: 607-610, 2002.
39. Urbina EM, Gidding SS, Bao W, Elkasabany A, Berenson GS. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: the Bogalusa Heart Study. Am Heart J 138: 122-127, 1999.
40. Van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res 92:10-18, 2011.
41. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129: 35-43, 1997.
42. Velan SS, Durst C, Lemieux SK, Raylman RR, Sridhar R, Spencer RG, Hobbs GR, Thomas MA. Investigation of muscle lipid metabolism by localized one-and two-dimensional MRS techniques using a clinical 3T MRI/MRS scanner. J Magn Reson Imaging 25: 192-199, 2007.
43. Velan SS, Ramamurthy S, Ainala S, Durst C, Lemieux SK, Raylman RR, Spencer RG, Thomas MA. Implementation and validation of localized constant-time correlated spectroscopy (LCT-COSY) on a clinical 3T MRI scanner for investigation of muscle metabolism. J Magn Reson Imaging 26: 410-417, 2007.
44. Velan SS, Said N, Durst C, Frisbee S, Frisbee J, Raylman RR, Thomas MA, Rajendran VM, Spencer RG, Alway SE. Distinct patterns of fat metabolism in skeletal muscle of normal-weight, overweight, and obese humans. Am J Physiol Regul Integr Comp Physiol 295: R1060-R1065, 2008.
45. Verma S, Dumont AS, McNeill JH. Myocardial insulin resistance in cardiac hypertrophy. Cardiovasc Res 42: 12-14, 1999.
46. Wende AR, Abel ED. Lipotoxicity in the heart. Biochim Biophys Acta 1801: 311-319, 2010.
47. Wilson CR, Tran MK, Salazar KL, Young ME, Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 406: 457-467, 2007.
48. Yang J, Sambandam N, Han X, Gross RW, Courtois M, Kovacs A, Febbraio M, Finck BN, Kelly DP. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 100: 1208-1217, 2007.
49. Yin FC, Spurgeon HA, Rakusan K, weisfeldt ML, Lakatta EG. Use Of tibial length to quantify cardiac hypertrophy application in the aging rat. Am J Physiol Heart Circ Physiol 243: H941-H947, 1982.